Azure Medical, Inc.
UnclaimedIn-Vitro Diagnostic Substance ManufacturingLa Verne, CA
Founded
2023
Primary NAICS
325413
CAGE code
9NED1
Federal awards
$61.2M
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- In-Vitro Diagnostic Substance Manufacturing325413
Capabilities
Pharmaceutical Preparation ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingResearch and Development in NanotechnologyResearch and Development in Biotechnology (except Nanobiotechnology)Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)Medical LaboratoriesIn Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2025 | Department of Health and Human Services | $0 | 1 |
| 2024 | Department of Health and Human Services | $0 | 3 |
| 2023 | Department of Health and Human Services | $61,236,000 | 1 |